Global Cytomegalovirus Disease Treatments Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Cytomegalovirus Disease Treatments Market Overview

• 1.1 Product Overview and Scope of Cytomegalovirus Disease Treatments
• 1.2 Classification of Cytomegalovirus Disease Treatments by Types
  • 1.2.1 Global Cytomegalovirus Disease Treatments Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Cytomegalovirus Disease Treatments Revenue Market Share by Types in 2018
  • 1.2.3 Ganciclovir
  • 1.2.4 Valganciclovir
  • 1.2.5 Foscarnet
  • 1.2.6 Cidofovir
  • 1.2.7 Others
• 1.3 Global Cytomegalovirus Disease Treatments Market by Application
  • 1.3.1 Global Cytomegalovirus Disease Treatments Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Stem Cell Transplantation
  • 1.3.3 Organ Transplantation
  • 1.3.4 Congenital CMV Infection
  • 1.3.5 Others
• 1.4 Global Cytomegalovirus Disease Treatments Market by Regions
  • 1.4.1 Global Cytomegalovirus Disease Treatments Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Cytomegalovirus Disease Treatments Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Cytomegalovirus Disease Treatments Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cytomegalovirus Disease Treatments Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Cytomegalovirus Disease Treatments Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cytomegalovirus Disease Treatments Status and Prospect (2014-2024)
• 1.5 Global Market Size of Cytomegalovirus Disease Treatments (2014-2024)

2 Manufacturers Profiles

• 2.1 Merck
  • 2.1.1 Business Overview
  • 2.1.2 Cytomegalovirus Disease Treatments Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Merck Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Chimerix
  • 2.2.1 Business Overview
  • 2.2.2 Cytomegalovirus Disease Treatments Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Chimerix Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Abbott
  • 2.3.1 Business Overview
  • 2.3.2 Cytomegalovirus Disease Treatments Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Abbott Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bio-Rad
  • 2.4.1 Business Overview
  • 2.4.2 Cytomegalovirus Disease Treatments Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bio-Rad Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Roche
  • 2.5.1 Business Overview
  • 2.5.2 Cytomegalovirus Disease Treatments Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Roche Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Gilead Sciences
  • 2.6.1 Business Overview
  • 2.6.2 Cytomegalovirus Disease Treatments Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Gilead Sciences Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)

3 Global Cytomegalovirus Disease Treatments Market Competition, by Players

• 3.1 Global Cytomegalovirus Disease Treatments Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Cytomegalovirus Disease Treatments Players Market Share
  • 3.2.2 Top 10 Cytomegalovirus Disease Treatments Players Market Share
• 3.3 Market Competition Trend

4 Global Cytomegalovirus Disease Treatments Market Size by Regions

• 4.1 Global Cytomegalovirus Disease Treatments Revenue and Market Share by Regions
• 4.2 North America Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 4.3 Europe Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 4.5 South America Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)

5 North America Cytomegalovirus Disease Treatments Revenue by Countries

• 5.1 North America Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
• 5.2 USA Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 5.3 Canada Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)

6 Europe Cytomegalovirus Disease Treatments Revenue by Countries

• 6.1 Europe Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
• 6.2 Germany Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 6.3 UK Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 6.4 France Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 6.5 Russia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 6.6 Italy Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Cytomegalovirus Disease Treatments Revenue by Countries

• 7.1 Asia-Pacific Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
• 7.2 China Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 7.3 Japan Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 7.4 Korea Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 7.5 India Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)

8 South America Cytomegalovirus Disease Treatments Revenue by Countries

• 8.1 South America Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
• 8.2 Brazil Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Cytomegalovirus Disease Treatments by Countries

• 9.1 Middle East and Africa Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 9.3 UAE Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)

10 Global Cytomegalovirus Disease Treatments Market Segment by Type

• 10.1 Global Cytomegalovirus Disease Treatments Revenue and Market Share by Type (2014-2019)
• 10.2 Global Cytomegalovirus Disease Treatments Market Forecast by Type (2019-2024)
• 10.3 Ganciclovir Revenue Growth Rate (2014-2024)
• 10.4 Valganciclovir Revenue Growth Rate (2014-2024)
• 10.5 Foscarnet Revenue Growth Rate (2014-2024)
• 10.6 Cidofovir Revenue Growth Rate (2014-2024)
• 10.7 Others Revenue Growth Rate (2014-2024)

11 Global Cytomegalovirus Disease Treatments Market Segment by Application

• 11.1 Global Cytomegalovirus Disease Treatments Revenue Market Share by Application (2014-2019)
• 11.2 Cytomegalovirus Disease Treatments Market Forecast by Application (2019-2024)
• 11.3 Stem Cell Transplantation Revenue Growth (2014-2019)
• 11.4 Organ Transplantation Revenue Growth (2014-2019)
• 11.5 Congenital CMV Infection Revenue Growth (2014-2019)
• 11.6 Others Revenue Growth (2014-2019)

12 Global Cytomegalovirus Disease Treatments Market Size Forecast (2019-2024)

• 12.1 Global Cytomegalovirus Disease Treatments Market Size Forecast (2019-2024)
• 12.2 Global Cytomegalovirus Disease Treatments Market Forecast by Regions (2019-2024)
• 12.3 North America Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
• 12.4 Europe Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
• 12.6 South America Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology